Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: A population-based study Academic Article uri icon

Overview

MeSH Major

  • Myeloproliferative Disorders

abstract

  • We found patients with any MPN subtype to have significantly reduced life expectancy compared with the general population. The improvement over time is most likely explained by better overall clinical management of patients with MPN. The decreased life expectancy even in the most recent calendar period emphasizes the need for new treatment options for these patients.

publication date

  • August 20, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3417050

Digital Object Identifier (DOI)

  • 10.1200/JCO.2012.42.1925

PubMed ID

  • 22802311

Additional Document Info

start page

  • 2995

end page

  • 3001

volume

  • 30

number

  • 24